Results: 3

suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva: um estudo piloto

RESUMO Objetivo: Determinar o desempenho da dosagem do receptor ativador de plasminogênio tipo uroquinase solúvel quando da alta da unidade de terapia intensiva para predição da mortalidade após permanência na mesma unidade. Métodos: Durante 24 meses conduziu-se um estudo prospectivo observacion...

Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD

J. bras. pneumol; 44 (1), 2018
ABSTRACT Objective: To evaluate the value of soluble urokinase-type plasminogen activator receptor (suPAR) in the diagnosis of acute exacerbation of COPD (AECOPD) and in monitoring treatment response, analyzing the relationship between suPAR and fibrinogen in AECOPD. AECOPD leads to increased airway inf...

SCUBE1: a promising biomarker in renal cell cancer

Int. braz. j. urol; 43 (4), 2017
ABSTRACT Purpose To investigate the efficacy of signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) as a novel biomarker of renal tumors. Materials and Methods 48 individuals were included in the study. The patient group (Group-1) consisted of 23 subjects diagnosed with renal tumor, and the ...